This paper constitutes an attempt at investigating processes of dynamic competition in pharmaceuticals, with reference to the nature and intensity of price competition in relation to patent expiry.We focus on what happens to drug prices and to the diffusion of multi-sourceproducts both before...

The expert contributors to this book examine recent developments in empirical methods and applied simulation in evolutionary economics. Using examples of innovation and technology in industry, it is the first book to address the following questions in a systematic manner: Can evolutionary...

We draw on diverse data sets to compare the institutional organization of upstream life science research across the United States and Europe. Understanding cross-national differences in the organization of innovative labor in the life sciences requires attention to the structure and evolution of...

We provide a detailed analysis of a model of innovation and corporate dynamics that encompasses the Gibrat's Law of Proportionate Effect and the Simon growth process as particular instances. The predictions of the model are derived in terms of (i) firm size distribution, (ii) the distribution of...

All'indomani della pubblicazione della bozza di Finanziaria-2008, il Quaderno invita a riflettere su alcuni aspetti critici dell'articolo 5 in tema di spesa farmaceutica pubblica. L'analisi comparata delle dinamiche di settore/mercato induce a suggerire che: (a) le modalità di pricing al lancio...